Synthesis and the activity assessment of adamantylcontaining thiazolium inhibitors of butyrylcholinesterase

Autor: Ocheretniuk, A. D., Kobzar, O. L., Kozachenko, O. P., Brovarets, V. S., Vovk, A. I.

Publikováno v: Журнал органічної та фармацевтичної хімії; Том 15, № 4(60) (2017): Журнал органічної та фармацевтичної хімії; 48-55
Žurnal organìčnoï ta farmacevtičnoï hìmìï; Том 15, № 4(60) (2017): Žurnal organìčnoï ta farmacevtičnoï hìmìï; 48-55
Журнал органической и фармацевтической химии; Том 15, № 4(60) (2017): Журнал органической и фармацевтической химии; 48-55

Cholinesterase inhibitors can be used for treatment of neuropsychiatric symptoms and functional impairments in neurodegenerative pathologies such as Alzheimer’s and Parkinson’s diseases.Aim. To synthesize and assess the inhibitory activity of ada

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=scientific_p::6638302ec9ff73ded0548326b8021401
http://ophcj.nuph.edu.ua/article/view/ophcj.17.926

QSAR Study of Some 1,3-Oxazolylphosphonium Derivatives as New Potent Anti-CandidaAgents and Their Toxicity Evaluation

Autor: Trush, Maria M., Kovalishyn, Vasyl, Ocheretniuk, Alla D., Kobzar, Oleksandr L., Kachaeva, Maryna V., Brovarets, Volodymyr S., Metelytsia, Larisa O.

Publikováno v: Current Drug Discovery Technologies; June 2019, Vol. 16 Issue: 2 p204-209, 6p